Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Axogen Inc (NASDAQ: AXGN) closed the day trading at $18.99 up 1.01% from the previous closing price of $18.80. In other words, the price has increased by $1.01 from its previous closing price. On the day, 0.66 million shares were traded. AXGN stock price reached its highest trading level at $19.33 during the session, while it also had its lowest trading level at $18.67.
Ratios:
For a better understanding of AXGN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 588.87. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 19 ’25 when DeVinney Erick Wayne sold 15,111 shares for $17.50 per share. The transaction valued at 264,442 led to the insider holds 217,762 shares of the business.
Wendell Amy McBride sold 5,000 shares of AXGN for $100,100 on Mar 03 ’25. The Director now owns 97,899 shares after completing the transaction at $20.02 per share. On Mar 03 ’25, another insider, AMY MCBRIDE-WENDELL, who serves as the Director of the company, bought 5,000 shares for $20.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 842088768 and an Enterprise Value of 879692480. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.49 while its Price-to-Book (P/B) ratio in mrq is 8.07. Its current Enterprise Value per Revenue stands at 4.696 whereas that against EBITDA is 255.205.
Stock Price History:
The Beta on a monthly basis for AXGN is 0.99, which has changed by 1.3886793 over the last 52 weeks, in comparison to a change of 0.08572841 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $21.00, while it has fallen to a 52-week low of $5.55. The 50-Day Moving Average of the stock is 3.85%, while the 200-Day Moving Average is calculated to be 37.48%.
Shares Statistics:
Over the past 3-months, AXGN traded about 541.47K shares per day on average, while over the past 10 days, AXGN traded about 539620 shares per day. A total of 44.15M shares are outstanding, with a floating share count of 41.83M. Insiders hold about 5.67% of the company’s shares, while institutions hold 81.67% stake in the company. Shares short for AXGN as of 1741910400 were 1512762 with a Short Ratio of 2.79, compared to 1739491200 on 1853763. Therefore, it implies a Short% of Shares Outstanding of 1512762 and a Short% of Float of 4.04.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
